Literature DB >> 15100717

Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects.

A Geelen1, I A Brouwer, E G Schouten, C Kluft, M B Katan, P L Zock.   

Abstract

OBJECTIVE: High-sensitivity C-reactive protein (CRP), a marker of systemic inflammation, is a powerful predictor of cardiovascular risk. We hypothesised that n-3 fatty acids reduce underlying inflammatory processes and consequently CRP concentrations in healthy middle-aged subjects.
DESIGN: Placebo-controlled, double-blind study.
SUBJECTS: A total of 43 men and 41 postmenopausal women aged 50-70 y. Before and after intervention, we measured serum CRP concentrations with an enzyme immunoassay.
INTERVENTIONS: Capsules with either 3.5 g/day fish oil (1.5 g/day n-3 fatty acids) or placebo for 12 weeks.
RESULTS: The median CRP change in the fish oil group did not significantly differ from that in the placebo group (0.01 vs -0.17 mg/l, P = 0.057).
CONCLUSION: The currently available data--including ours--do not support that beneficial effects on CRP are involved in a mechanism explaining the protective effect on heart disease risk of n-3 fatty acids as present in fish.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100717     DOI: 10.1038/sj.ejcn.1601986

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  24 in total

Review 1.  The effect of weight loss and dietary fatty acids on inflammation.

Authors:  Sridevi Devaraj; Sidika Kasim-Karakas; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

2.  Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome.

Authors:  Antonella Dewell; Farshad Fani Marvasti; William S Harris; Philip Tsao; Christopher D Gardner
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

Review 3.  Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

Authors:  Jian Shen; Jose M Ordovas
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

4.  Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos.

Authors:  Zeina Makhoul; Alan R Kristal; Roman Gulati; Bret Luick; Andrea Bersamin; Bert Boyer; Gerald V Mohatt
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

Review 5.  Omega-3 fatty acids and cognitive function in women.

Authors:  Jennifer G Robinson; Nkechinyere Ijioma; William Harris
Journal:  Womens Health (Lond)       Date:  2010-01

Review 6.  Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

Authors:  Megan F Burke; Frances M Burke; Daniel E Soffer
Journal:  Curr Atheroscler Rep       Date:  2017-11-07       Impact factor: 5.113

Review 7.  Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.

Authors:  Michael I Goran; Tanya L Alderete
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2012-10-29

8.  DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men.

Authors:  Darshan S Kelley; David Siegel; Dawn M Fedor; Yuriko Adkins; Bruce E Mackey
Journal:  J Nutr       Date:  2009-01-21       Impact factor: 4.798

9.  Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults.

Authors:  M F Muldoon; B Laderian; D C H Kuan; S M Sereika; A L Marsland; S B Manuck
Journal:  J Intern Med       Date:  2015-10-26       Impact factor: 8.989

10.  Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers.

Authors:  Stine M Ulven; Bente Kirkhus; Amandine Lamglait; Samar Basu; Elisabeth Elind; Trond Haider; Kjetil Berge; Hogne Vik; Jan I Pedersen
Journal:  Lipids       Date:  2010-11-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.